Moderna
Stock Forecast, Prediction & Price Target

Moderna (MRNA) stock Price Target by analysts

Last Year
Average Price Target

$92.9

Potential upside: 234.77%

Based on 8 analysts

Moderna price prediction

Strike.market

What is Moderna stock analysts` prediction?

Moderna stock forecast: Based on 8 Wall Street analysts` predicted price targets for Moderna in the last 3 months, the avarage price target is $92.9, with a high forecast of $NaN. The average price target represents a 234.77% change from the last price of $27.75.

Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.

Moderna stock Price Target by analysts

Full breakdown of analysts given Moderna price targets

Analyst name & company
Analyst win rate
Publish date
Price target
Price when posted
Source Historical targets
Edward Tenthoff
Piper Sandler
0%
0/5
10 months ago $69 148.64% upside $37.27 StreetInsider
Previous targets (4)
Yifeng Liu
HSBC
0%
0/2
10 months ago $58 109.00% upside $84.93 StreetInsider
Previous targets (1)
Courtney Breen
Bernstein
0%
0/1
11 months ago $55 98.19% upside $57.46 TheFly
Previous targets (0)
Michael Yee
Jefferies
33.33%
2/6
11 months ago $55 98.19% upside $57.73 TheFly
Previous targets (5)
Edward Tenthoff
Piper Sandler
0%
0/5
12 months ago $115 314.41% upside $69.68 StreetInsider
Previous targets (4)
Luca Issi
RBC Capital
0%
0/4
12 months ago $75 170.27% upside $69.68 StreetInsider
Previous targets (3)
Leah Rush Cann
Loop Capital Markets
0%
0/2
12 months ago $238 757.65% upside $69.68 StreetInsider
Previous targets (1)
Matthew Harrison
Morgan Stanley
50%
3/6
12 months ago $94 238.73% upside $67.51 StreetInsider
Previous targets (5)
Michael Yee
Jefferies
33.33%
2/6
12 months ago $65 134.23% upside $69.68 TheFly
Previous targets (5)
Cory Kasimov
Evercore ISI
0%
0/2
12 months ago $105 278.37% upside $67.68 StreetInsider
Previous targets (1)
Peter Arment
Robert W. Baird
0%
0/1
about 1 year ago $220 692.79% upside $78.52 Benzinga
Previous targets (0)
Yifeng Liu
HSBC
0%
0/2
about 1 year ago $82 195.49% upside $78.98 TheFly
Previous targets (1)
Emmanuel Papadakis
Deutsche Bank
25%
1/4
about 1 year ago $80 188.28% upside $82.3 TheFly
Previous targets (3)
Luca Issi
RBC Capital
0%
0/4
about 1 year ago $90 224.32% upside $86.58 TheFly
Previous targets (3)
Edward Tenthoff
Piper Sandler
0%
0/5
about 1 year ago $157 465.76% upside $90.03 TheFly
Previous targets (4)
Hartaj Singh
Oppenheimer
0%
0/3
about 1 year ago $179 545.04% upside $148.39 TheFly
Previous targets (2)
Leah Rush Cann
Loop Capital Markets
0%
0/2
about 1 year ago $310 1017.11% upside $147.47 StreetInsider
Previous targets (1)
Michael Yee
Jefferies
33.33%
2/6
about 1 year ago $180 548.64% upside $152.03 TheFly
Previous targets (5)
Luca Issi
RBC Capital
0%
0/4
over 1 year ago $160 476.57% upside $141.83 TheFly
Previous targets (3)
Cory Kasimov
Evercore ISI
0%
0/2
over 1 year ago $120 332.43% upside $125.67 StreetInsider
Previous targets (1)
Emmanuel Papadakis
Deutsche Bank
25%
1/4
over 1 year ago $85 206.30% upside $124.06 TheFly
Previous targets (3)
Eliana Merle
UBS
0%
0/4
over 1 year ago $151 444.14% upside $122.13 TheFly
Previous targets (3)
Bill Maughan
Canaccord Genuity
50%
1/2
over 1 year ago $106 281.98% upside $125.59 TheFly
Previous targets (1)
Michael Yee
Jefferies
33.33%
2/6
over 1 year ago $155 458.55% upside $123.02 TheFly
Previous targets (5)
Hartaj Singh
Oppenheimer
0%
0/3
over 1 year ago $163 487.38% upside $125.59 StreetInsider
Previous targets (2)
Luca Issi
RBC Capital
0%
0/4
over 1 year ago $135 386.48% upside $125.59 StreetInsider
Previous targets (3)
Matthew Harrison
Morgan Stanley
50%
3/6
over 1 year ago $95 242.34% upside $125 StreetInsider
Previous targets (5)
Matthew Harrison
Morgan Stanley
50%
3/6
over 1 year ago $89 220.72% upside $108.85 StreetInsider
Previous targets (5)
Michael Yee
Jefferies
33.33%
2/6
over 1 year ago $125 350.45% upside $110.59 StreetInsider
Previous targets (5)
Eliana Merle
UBS
0%
0/4
over 1 year ago $143 415.31% upside $107.41 StreetInsider
Previous targets (3)
Bill Maughan
Canaccord Genuity
50%
1/2
over 1 year ago $82 195.49% upside $87.59 Benzinga
Previous targets (1)
Matthew Harrison
Morgan Stanley
50%
3/6
over 1 year ago $123 343.24% upside $87.59 Benzinga
Previous targets (5)
Hartaj Singh
Oppenheimer
0%
0/3
over 1 year ago $142 411.71% upside $113.15 Benzinga
Previous targets (2)
Eliana Merle
UBS
0%
0/4
about 2 years ago $191 588.28% upside $121.14 Benzinga
Previous targets (3)
Unknown
Piper Sandler
N/A
over 2 years ago $217 681.98% upside $189.89 Benzinga
N/A
Unknown
Jefferies
N/A
over 2 years ago $275 890.99% upside $193.29 Benzinga
N/A
Unknown
Morgan Stanley
N/A
over 2 years ago $209 653.15% upside $191.78 Benzinga
N/A
Unknown
Chardan Capital
N/A
over 2 years ago $191 588.28% upside $212.41 Benzinga
N/A
Unknown
Leerink Partners
N/A
over 2 years ago $102 267.56% upside $197.54 Benzinga
N/A
Jasper Hellweg Hellweg
Argus Research
100%
1/1
almost 3 years ago $150 440.54% upside $123.64 Pulse 2.0
Previous targets (0)
Edward Tenthoff
Piper Sandler
0%
0/5
over 3 years ago $214 671.17% upside $142.28 TheFly
Previous targets (4)
Matthew Harrison
Morgan Stanley
50%
3/6
over 3 years ago $199 617.11% upside $155.05 Pulse 2.0
Previous targets (5)
Edward Tenthoff
Piper Sandler
0%
0/5
over 3 years ago $348 1154.05% upside $176.59 Pulse 2.0
Previous targets (4)
Matthew Harrison
Morgan Stanley
50%
3/6
over 3 years ago $205 638.73% upside $173.08 Pulse 2.0
Previous targets (5)
Emmanuel Papadakis
Deutsche Bank
25%
1/4
over 3 years ago $155 458.55% upside $129.28 Pulse 2.0
Previous targets (3)
Michael Yee
Jefferies
33.33%
2/6
over 3 years ago $170 512.61% upside $151.33 Pulse 2.0
Previous targets (5)
Gena Wang
Barclays
0%
0/1
over 3 years ago $210 656.75% upside $156.23 TipRanks Contributor
Previous targets (0)
Tyler Van Buren
Cowen & Co.
100%
1/1
over 3 years ago $200 620.72% upside $172.74 Pulse 2.0
Previous targets (0)
Emmanuel Papadakis
Deutsche Bank
25%
1/4
over 3 years ago $175 530.63% upside $154.96 Pulse 2.0
Previous targets (3)
Eliana Merle
UBS
0%
0/4
over 3 years ago $221 696.39% upside $160.07 TheFly
Previous targets (3)

Moderna Financial Estimates

Moderna Revenue Estimates

Moderna EBITDA Estimates

Moderna Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$17.73B
 
N/A
$19.26B
 
8.60%
$6.84B
 
-64.44%
Avg: $4.80B
Low: $3.85B
High: $6.76B
avg. -29.77%
Avg: $6.55B
Low: $5.49B
High: $8.03B
avg. 36.29%
Avg: $9.03B
Low: $7.57B
High: $11.06B
avg. 37.81%
Avg: $12.45B
Low: $10.44B
High: $15.26B
avg. 37.92%
Net Income
 
% change YoY
$12.20B
 
N/A
$8.36B
 
-31.47%
$-4.71B
 
-156.37%
Avg: $-2.05B
Low: $-2.74B
High: $-378.18M
avg. 56.42%
Avg: $-482.39M
Low: $-2.31B
High: $4.95B
avg. 76.51%
Avg: $926.29M
Low: $731.61M
High: $1.19B
avg. 292.02%
Avg: $3.05B
Low: $2.41B
High: $3.94B
avg. 229.82%
EBITDA
 
% change YoY
$13.29B
 
N/A
$9.76B
 
-26.53%
$-3.28B
 
-133.60%
Avg: $-1.17B
Low: $-1.64B
High: $-938.59M
avg. 64.29%
Avg: $-1.59B
Low: $-1.95B
High: $-1.33B
avg. -36.29%
Avg: $-2.20B
Low: $-2.69B
High: $-1.84B
avg. -37.81%
Avg: $-3.03B
Low: $-3.72B
High: $-2.54B
avg. -37.92%
EPS
 
% change YoY
$30.28
 
N/A
$21.22
 
-29.92%
-$12.34
 
-158.15%
Avg: -$5.26
Low: -$7.19
High: -$0.99
avg. 57.39%
Avg: -$1.65
Low: -$6.05
High: $12.97
avg. 68.70%
Avg: $2.42
Low: $1.92
High: $3.13
avg. 247.36%
Avg: $8
Low: $6.32
High: $10.34
avg. 229.82%
Operating Expenses
 
% change YoY
$1.82B
 
N/A
$4.42B
 
142.84%
$6.39B
 
44.43%
Avg: $3.16B
Low: $2.53B
High: $4.44B
avg. -50.54%
Avg: $4.31B
Low: $3.61B
High: $5.28B
avg. 36.29%
Avg: $5.93B
Low: $4.97B
High: $7.27B
avg. 37.81%
Avg: $8.19B
Low: $6.86B
High: $10.03B
avg. 37.92%

FAQ

What is Moderna stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 163.69% in 2025-2028.

We have gathered data from 18 analysts. Their low estimate is -2.74B, average is -2.05B and high is -378.18M.

What is Moderna stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 20.56% in 2025-2028.

We have gathered data from 18 analysts. Their low revenue estimate is $3.85B, average is $4.80B and high is $6.76B.

What is Moderna stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 150.81% in 2025-2028.

We have gathered data from 18 analysts. Their low earnings per share estimate is -$7.19, average is -$5.26 and high is $-0.99.

What is the best performing analyst?

In the last twelve months 8 analysts have been covering Moderna stock. The most successful analyst is Edward Tenthoff.